XML 37 R28.htm IDEA: XBRL DOCUMENT v3.22.2
Common Stock (Tables)
 3 Months Ended
May 31, 2022
Equity [Abstract]  
Schedule of outstanding share purchase warrants
          
   Number of
Warrants		   Weighted Average
Exercise Price		 
Balance, February 28, 2020   —   $— 
Issued in Connection with October 2020 Offering   488,500   $2.10 
Issued in connection with January 2021 Offering   1,604,334   $3.00 
Exercised   (25,000)  $2.00 
Balance, February 28, 2021   2,067,834   $2.80 
Exercised   (221,666)  $2.44 
Balance, February 28, 2022   1,846,168   $2.84 
 Exercised   —    — 
Balance, May 31, 2022   1,846,168   $2.84 
Schedule of Summary of share purchase warrants outstanding and exercisable
               
    Number of Warrants   Remaining Contractual    
Exercise Price   Outstanding   Life (Years)   Expiry Date
$2.00    288,500    0.38   18-Oct-22
$3.00    50,000    0.38   18-Oct-22
$3.00    1,507,668    0.62   12-Jan-23
$2.84    1,846,168         
Schedule of valuation assumptions
          
   May 31,
2022		   February 28,
2022		 
Expected Risk Free Interest Rate   1.06%   1.06%
Expected Volatility   15.27%   15.27%
Expected Life in Years   5.0    5.0 
Expected Dividend Yield   —    — 
Weighted-Average Grant Date Fair Value  $6.46   $6.46 
Schedule of stock option activity
          
   Number of Stock Options   Exercise Price 
Balance, February 28, 2022   4,545,500   $8.00 
Granted   —    — 
Cancelled/Forfeited   —    — 
Expired   —    — 
Balance, May 31, 2022   4,545,500   $8.00 
Schedule of number of issued shares and cash received upon exercise of stock options
          
    May 31,
2022		    February 28,
2022		 
Number of Options Exercised on Forfeiture Basis   —    — 
Number of Options Exercised on Cash Basis   —    — 
Total Number of Options Exercised   —    — 
           
Number of Shares Issued on Cash Exercise   —    — 
Number of Shares Issued on Forfeiture Basis   —    — 
Total Number of Shares Issued Upon Exercise of Options   —    — 
           
Cash Received from Exercise of Stock Options  $—   $— 
Total Intrinsic Value of Options Exercised  $—   $— 
Schedule of unvested restricted stock
          
   Number of Unvested   Weighted Average 
   Stock
Options		   Grant Date Fair Value 
Balance, February 28, 2021   —    — 
Granted   4,545,500   $6.46 
Vested   (909,000)  $6.46 
Balance, February 28, 2022   3,636,500   $6.46 
Granted   —    — 
Vested   —    — 
Balance, May 31, 2022   3,636,500   $6.46 
Schedule of Stock Options
                                
    Options Outstanding   Options Exercisable 
Range of Exercise Prices  

Outstanding at

May 31, 2022

   Exercise Price  

Weighted Average Remaining

Contractual Term

(Years)

   Exercisable at May 31, 2022   Exercise Price  

Weighted Average Remaining

Contractual Term

(Years)

 
 $ 7.00 to $ 9.00    4,545,500   $8.00    4.58    909,000   $8.00    4.58 
                                 
      4,545,500   $8.00    4.58    909,000   $8.00    4.58